Medplus Health Services Limited (MEDPLUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has a cash flow conversion efficiency ratio of 0.074x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.14 Billion ≈ $12.35 Million USD) by net assets (Rs15.46 Billion ≈ $167.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medplus Health Services Limited - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Medplus Health Services Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDPLUS total liabilities for a breakdown of total debt and financial obligations.
Medplus Health Services Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medplus Health Services Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Yimikang Environmental Tech Co Ltd
SHE:300249
|
0.051x |
|
Hunan Keli Motor Co Ltd
SHE:002892
|
0.042x |
|
Phibro Animal Health Corporation
NASDAQ:PAHC
|
0.058x |
|
Jiangsu Gian Technology Co Ltd
SHE:300709
|
0.202x |
|
Sixt SE
XETRA:SIX3
|
0.081x |
|
Mader Group Ltd
AU:MAD
|
0.132x |
|
Aevis Victoria SA
SW:AEVS
|
0.037x |
|
Taiflex Scientific Co Ltd
TW:8039
|
0.090x |
Annual Cash Flow Conversion Efficiency for Medplus Health Services Limited (2019–2025)
The table below shows the annual cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see MEDPLUS company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs17.40 Billion ≈ $188.16 Million |
Rs5.54 Billion ≈ $59.96 Million |
0.319x | +249.68% |
| 2024-03-31 | Rs15.77 Billion ≈ $170.59 Million |
Rs1.44 Billion ≈ $15.54 Million |
0.091x | +50.23% |
| 2023-03-31 | Rs14.91 Billion ≈ $161.19 Million |
Rs904.10 Million ≈ $9.78 Million |
0.061x | -49.40% |
| 2022-03-31 | Rs14.17 Billion ≈ $153.27 Million |
Rs1.70 Billion ≈ $18.37 Million |
0.120x | +2931.44% |
| 2021-03-31 | Rs7.31 Billion ≈ $79.07 Million |
Rs28.91 Million ≈ $312.65K |
0.004x | +131.75% |
| 2020-03-31 | Rs5.29 Billion ≈ $57.22 Million |
Rs-65.89 Million ≈ $-712.58K |
-0.012x | -102.47% |
| 2019-03-31 | Rs2.91 Billion ≈ $31.51 Million |
Rs1.47 Billion ≈ $15.86 Million |
0.503x | -- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more